Moreover, another meta-analysis of 3,426 patients with early diabetic nephropathy concluded that statins could increase eGFR, reduce serum creatinine (Scr), and decrease C-reactive protein (CRP) level, thus reducing the inflammatory response and protecting the kidney (33). This evidence concerns the gene CRP and diabetic kidney disease.